Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts

Stephen M. Twigg, Alison H. Joly, Michelle M. Chen, Junko Tsubaki, K. I M Ho-Seong, H. W A Vivian, O. H. Youngman, Ronald (Ron) Rosenfeld

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Expansion of extracellular matrix with fibrosis occurs in many tissues, including skin, as part of the end-organ complications in diabetes. Advanced glycosylation end-products (AGEs) have been implicated as a pathogenic factor in diabetic tissue fibrosis. Connective tissue growth factor (CTGF), also known as IGF-binding protein-related protein-2, induces extracellular matrix. We have recently shown that CTGF mRNA and protein are up-regulated by AGE treatment of cultured human dermal fibroblasts. The aim of this study was to determine whether CTGF is an autocrine mediator in the induction of fibronectin (FN) by AGE. Primary cultures of non-fetal human dermal fibroblasts in confluent monolayer were treated with synthesized soluble AGE BSA, 0-200 μg/ml. Analysis of mRNA, by quantitative real-time RT-PCR and conditioned media from treated cultures, showed that FN mRNA was increased by approximately 4-fold at 48 h, and FN protein levels by Western immunoblot and FN ELISA were doubled, compared with control. In the same system, added recombinant human CTGF (0-500 ng/ml) induced FN mRNA and protein levels dose dependently and in a rapid time course. To test whether AGE BSA acts through cell-derived CTGF to induce FN, a CTGF neutralizing antibody was shown to significantly attenuate, but not fully inhibit, the AGE induction of FN mRNA. A pan-specific PKC inhibitor, GF109203X, at 0.2 μM, inhibited the induction of FN mRNA by AGE BSA. Although the same inhibitor did not significantly affect the induction of CTGF mRNA by AGE, it blocked the induction of FN mRNA by recombinant human CTGF. In summary, the induction of FN by AGE is partly mediated by the AGE-induced up-regulation of cell-derived CTGF and is dependent on PKC activity. These results have potential implications for the expansion of extracellular matrix in diabetes mellitus by advanced glycosylation end products.

Original languageEnglish (US)
Pages (from-to)1260-1269
Number of pages10
JournalEndocrinology
Volume143
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Connective Tissue Growth Factor
Advanced Glycosylation End Products
Fibronectins
Fibroblasts
Skin
Messenger RNA
Extracellular Matrix
Fibrosis
Proteins
Diabetes Complications
Conditioned Culture Medium
Neutralizing Antibodies
Real-Time Polymerase Chain Reaction
Diabetes Mellitus
Up-Regulation
Western Blotting
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts. / Twigg, Stephen M.; Joly, Alison H.; Chen, Michelle M.; Tsubaki, Junko; Ho-Seong, K. I M; Vivian, H. W A; Youngman, O. H.; Rosenfeld, Ronald (Ron).

In: Endocrinology, Vol. 143, No. 4, 2002, p. 1260-1269.

Research output: Contribution to journalArticle

Twigg, Stephen M. ; Joly, Alison H. ; Chen, Michelle M. ; Tsubaki, Junko ; Ho-Seong, K. I M ; Vivian, H. W A ; Youngman, O. H. ; Rosenfeld, Ronald (Ron). / Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts. In: Endocrinology. 2002 ; Vol. 143, No. 4. pp. 1260-1269.
@article{71ddc67bd26a4a69ad10628209f1ee8c,
title = "Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts",
abstract = "Expansion of extracellular matrix with fibrosis occurs in many tissues, including skin, as part of the end-organ complications in diabetes. Advanced glycosylation end-products (AGEs) have been implicated as a pathogenic factor in diabetic tissue fibrosis. Connective tissue growth factor (CTGF), also known as IGF-binding protein-related protein-2, induces extracellular matrix. We have recently shown that CTGF mRNA and protein are up-regulated by AGE treatment of cultured human dermal fibroblasts. The aim of this study was to determine whether CTGF is an autocrine mediator in the induction of fibronectin (FN) by AGE. Primary cultures of non-fetal human dermal fibroblasts in confluent monolayer were treated with synthesized soluble AGE BSA, 0-200 μg/ml. Analysis of mRNA, by quantitative real-time RT-PCR and conditioned media from treated cultures, showed that FN mRNA was increased by approximately 4-fold at 48 h, and FN protein levels by Western immunoblot and FN ELISA were doubled, compared with control. In the same system, added recombinant human CTGF (0-500 ng/ml) induced FN mRNA and protein levels dose dependently and in a rapid time course. To test whether AGE BSA acts through cell-derived CTGF to induce FN, a CTGF neutralizing antibody was shown to significantly attenuate, but not fully inhibit, the AGE induction of FN mRNA. A pan-specific PKC inhibitor, GF109203X, at 0.2 μM, inhibited the induction of FN mRNA by AGE BSA. Although the same inhibitor did not significantly affect the induction of CTGF mRNA by AGE, it blocked the induction of FN mRNA by recombinant human CTGF. In summary, the induction of FN by AGE is partly mediated by the AGE-induced up-regulation of cell-derived CTGF and is dependent on PKC activity. These results have potential implications for the expansion of extracellular matrix in diabetes mellitus by advanced glycosylation end products.",
author = "Twigg, {Stephen M.} and Joly, {Alison H.} and Chen, {Michelle M.} and Junko Tsubaki and Ho-Seong, {K. I M} and Vivian, {H. W A} and Youngman, {O. H.} and Rosenfeld, {Ronald (Ron)}",
year = "2002",
doi = "10.1210/en.143.4.1260",
language = "English (US)",
volume = "143",
pages = "1260--1269",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts

AU - Twigg, Stephen M.

AU - Joly, Alison H.

AU - Chen, Michelle M.

AU - Tsubaki, Junko

AU - Ho-Seong, K. I M

AU - Vivian, H. W A

AU - Youngman, O. H.

AU - Rosenfeld, Ronald (Ron)

PY - 2002

Y1 - 2002

N2 - Expansion of extracellular matrix with fibrosis occurs in many tissues, including skin, as part of the end-organ complications in diabetes. Advanced glycosylation end-products (AGEs) have been implicated as a pathogenic factor in diabetic tissue fibrosis. Connective tissue growth factor (CTGF), also known as IGF-binding protein-related protein-2, induces extracellular matrix. We have recently shown that CTGF mRNA and protein are up-regulated by AGE treatment of cultured human dermal fibroblasts. The aim of this study was to determine whether CTGF is an autocrine mediator in the induction of fibronectin (FN) by AGE. Primary cultures of non-fetal human dermal fibroblasts in confluent monolayer were treated with synthesized soluble AGE BSA, 0-200 μg/ml. Analysis of mRNA, by quantitative real-time RT-PCR and conditioned media from treated cultures, showed that FN mRNA was increased by approximately 4-fold at 48 h, and FN protein levels by Western immunoblot and FN ELISA were doubled, compared with control. In the same system, added recombinant human CTGF (0-500 ng/ml) induced FN mRNA and protein levels dose dependently and in a rapid time course. To test whether AGE BSA acts through cell-derived CTGF to induce FN, a CTGF neutralizing antibody was shown to significantly attenuate, but not fully inhibit, the AGE induction of FN mRNA. A pan-specific PKC inhibitor, GF109203X, at 0.2 μM, inhibited the induction of FN mRNA by AGE BSA. Although the same inhibitor did not significantly affect the induction of CTGF mRNA by AGE, it blocked the induction of FN mRNA by recombinant human CTGF. In summary, the induction of FN by AGE is partly mediated by the AGE-induced up-regulation of cell-derived CTGF and is dependent on PKC activity. These results have potential implications for the expansion of extracellular matrix in diabetes mellitus by advanced glycosylation end products.

AB - Expansion of extracellular matrix with fibrosis occurs in many tissues, including skin, as part of the end-organ complications in diabetes. Advanced glycosylation end-products (AGEs) have been implicated as a pathogenic factor in diabetic tissue fibrosis. Connective tissue growth factor (CTGF), also known as IGF-binding protein-related protein-2, induces extracellular matrix. We have recently shown that CTGF mRNA and protein are up-regulated by AGE treatment of cultured human dermal fibroblasts. The aim of this study was to determine whether CTGF is an autocrine mediator in the induction of fibronectin (FN) by AGE. Primary cultures of non-fetal human dermal fibroblasts in confluent monolayer were treated with synthesized soluble AGE BSA, 0-200 μg/ml. Analysis of mRNA, by quantitative real-time RT-PCR and conditioned media from treated cultures, showed that FN mRNA was increased by approximately 4-fold at 48 h, and FN protein levels by Western immunoblot and FN ELISA were doubled, compared with control. In the same system, added recombinant human CTGF (0-500 ng/ml) induced FN mRNA and protein levels dose dependently and in a rapid time course. To test whether AGE BSA acts through cell-derived CTGF to induce FN, a CTGF neutralizing antibody was shown to significantly attenuate, but not fully inhibit, the AGE induction of FN mRNA. A pan-specific PKC inhibitor, GF109203X, at 0.2 μM, inhibited the induction of FN mRNA by AGE BSA. Although the same inhibitor did not significantly affect the induction of CTGF mRNA by AGE, it blocked the induction of FN mRNA by recombinant human CTGF. In summary, the induction of FN by AGE is partly mediated by the AGE-induced up-regulation of cell-derived CTGF and is dependent on PKC activity. These results have potential implications for the expansion of extracellular matrix in diabetes mellitus by advanced glycosylation end products.

UR - http://www.scopus.com/inward/record.url?scp=0036220465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036220465&partnerID=8YFLogxK

U2 - 10.1210/en.143.4.1260

DO - 10.1210/en.143.4.1260

M3 - Article

C2 - 11897682

AN - SCOPUS:0036220465

VL - 143

SP - 1260

EP - 1269

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 4

ER -